Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea · Delayed Price · Currency is KRW 2,365.00
+5.00 (0.21%)
At close: Aug 24, 2026
Korea Arlico Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 36,172 | 65,523 | 52,955 | 87,364 | 100,392 | 117,712 | |
Market Cap Growth | -46.97% | 23.73% | -39.39% | -12.98% | -14.71% | -17.59% |
Enterprise Value | 59,934 | 98,063 | 83,746 | 102,863 | 86,314 | 100,409 |
Last Close Price | 2360.00 | 4275.00 | 3397.16 | 5483.79 | 6160.30 | 7081.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 28.54 | 12.50 | 23.88 |
PS Ratio | 0.18 | 0.33 | 0.28 | 0.47 | 0.60 | 0.84 |
PB Ratio | 0.47 | 0.84 | 0.67 | 0.98 | 1.13 | 1.45 |
P/TBV Ratio | 0.53 | 0.94 | 0.73 | 1.07 | 1.23 | 1.53 |
P/FCF Ratio | 2.95 | 9.52 | - | - | - | 31.82 |
P/OCF Ratio | 2.46 | 6.56 | - | 12.22 | 20.76 | 13.13 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.30 | 0.49 | 0.44 | 0.55 | 0.52 | 0.72 |
EV/EBITDA Ratio | 22.26 | 16.56 | 57.52 | 13.11 | 6.65 | 13.57 |
EV/EBIT Ratio | - | 99.13 | - | 33.48 | 8.75 | 20.94 |
EV/FCF Ratio | 4.89 | 14.25 | - | - | - | 27.14 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.59 | 0.63 | 0.63 | 0.52 | 0.35 | 0.16 |
Debt / EBITDA Ratio | 16.64 | 8.28 | 34.65 | 5.90 | 2.40 | 1.70 |
Debt / FCF Ratio | 3.66 | 7.13 | - | - | - | 3.41 |
Net Debt / Equity Ratio | 0.31 | 0.36 | 0.39 | 0.17 | -0.01 | -0.20 |
Net Debt / EBITDA Ratio | 8.82 | 4.74 | 21.47 | 1.98 | -0.08 | -2.18 |
Net Debt / FCF Ratio | 1.94 | 4.08 | -2.59 | -0.95 | 0.08 | -4.36 |
Asset Turnover | 1.16 | 1.17 | 1.10 | 1.15 | 1.22 | 1.21 |
Inventory Turnover | 2.76 | 2.96 | 3.05 | 2.84 | 2.58 | 2.72 |
Quick Ratio | 0.63 | 0.66 | 0.66 | 0.76 | 0.91 | 1.43 |
Current Ratio | 1.09 | 1.12 | 1.14 | 1.19 | 1.43 | 2.04 |
Return on Equity (ROE) | -2.09% | -0.77% | -6.35% | 3.45% | 9.47% | 6.21% |
Return on Assets (ROA) | -0.65% | 0.36% | -1.86% | 1.17% | 4.49% | 2.59% |
Return on Invested Capital (ROIC) | -1.73% | 0.91% | -4.79% | 2.82% | 12.39% | 6.35% |
Return on Capital Employed (ROCE) | -1.90% | 1.00% | -5.30% | 3.00% | 10.20% | 5.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.49% | -0.92% | -10.12% | 3.50% | 8.00% | 4.19% |
FCF Yield | 33.85% | 10.51% | -22.82% | -18.58% | -14.08% | 3.14% |
Payout Ratio | - | - | - | 63.76% | 13.08% | 19.43% |
Buyback Yield / Dilution | -0.79% | -0.03% | 49.01% | -94.89% | -0.18% | 0.06% |